The Carlyle Group Inc. - Common Stock (CG)

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the ones that make you life-changing money.

As of January 7, 2026, the private equity industry is grappling with a "liquidity reckoning" that has fundamentally altered the landscape of alternative investments. After a decade of rapid expansion fueled by ultra-low interest rates, the sector is now facing a massive backlog of unrealized assets, record-low distributions, and a

As of early January 2026, the "Great Hesitation" that gripped the private equity landscape for nearly three years has officially thawed. With the Federal Reserve signaling a sustained period of interest rate stability and a "soft landing" successfully navigated in 2025, the massive reservoir of private equity "dry powder"—estimated

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developments. As such, investors are taking notice and bidding up shares.

The global healthcare landscape shifted decisively on December 16, 2025, with the public market return of Medline Industries (Nasdaq: MDLN). After four years under the stewardship of a private equity consortium—and decades of private family ownership before that—the medical supply titan has reclaimed its status as a public entity in the largest U.S. initial public [...]

As of December 25, 2025, the once-invincible aura surrounding the private equity (PE) industry has noticeably dimmed. For decades, private equity was the premier destination for institutional capital, promising "alpha" that consistently outpaced public indices. However, a grueling two-year stretch has seen many firms produce lackluster returns that significantly lag

As the 2025 holiday season reaches its peak, Advance Auto Parts (NYSE:AAP) has found itself at a critical crossroads. After a year defined by radical restructuring and a massive divestiture, the company is seeing a surge in investor interest driven by a mix of turnaround optimism and stark market

On December 23, 2025, Piper Sandler (NYSE: PIPR) sent a clear signal to the market regarding the trajectory of the financial services sector by significantly upgrading its outlook for SEI Investments (NASDAQ: SEIC). Analyst Crispin Love moved the firm’s rating from Neutral to Overweight and raised the price target

In a stunning return to the public stage, Medline Industries (Nasdaq: MDLN) successfully executed the largest initial public offering (IPO) in the United States since 2021, pricing its shares at the top of its range and witnessing a massive first-day "pop" that has sent ripples through the financial world. The

Long-time healthcare operations leader brings strategic insight, client-first vision, and operational excellence to board role

Proven healthcare leader to drive growth and product innovation in support of the company’s mission to accelerate better health outcomes

Shares of private equity firm Carlyle Group (NASDAQ:CG) jumped 3% in the afternoon session after reports surfaced that the private equity firm was in talks to acquire Japan-based medical products company Hogy Medical. The potential target had a market value of around $826 million. The positive sentiment was further supported by other business developments. Carlyle's Global Credit platform provided a €290 million financing package to Mecachrome Group, a European aerospace and defense components manufacturer.

Shares of private equity firm Carlyle Group (NASDAQ:CG) jumped 2.7% in the afternoon session after reports surfaced that the company was in talks to acquire a majority stake in an Indian home mortgage firm, Nido Home Finance. The discussions were reportedly part of a strategy to increase investments in India's financial services sector. According to sources familiar with the matter, Carlyle targeted an initial investment of $300 million in the Mumbai-based lender, which is owned by Edelweiss Financial Services Ltd. This potential deal highlighted a trend of global investors seeking more exposure to India's rapidly growing housing finance market, and the stock's movement suggested investors viewed the potential expansion positively.

Is it time to panic on the "safest" tech giant?

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Carlyle (NASDAQ:CG) and its peers.

The financial world is abuzz with the artificial intelligence (AI) revolution, but a recent pronouncement from the Carlyle Group casts a cautionary shadow, drawing striking parallels between the current AI spending frenzy and the early shale era's "growth at all costs" mentality. As of November 26, 2025, veteran commodity market

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.

ARMADA Parent Inc., a leading solutions provider for outsourced U.S. Navy ship repair and construction, today announced the acquisition of Poseidon Industrial LLC (“Poseidon”). Poseidon is a Virginia based company supporting the U.S. Navy and defense industry with mechanical, electrical, and systems integration services for modernization and repair projects. ARMADA, which is majority owned by Carlyle (NASDAQ: CG) and Stellex Capital Management, delivers integrated mission-critical solutions across its national footprint of operating companies that will be strengthened by this acquisition of Poseidon.

Carlyle’s third quarter results drew a negative market reaction as the firm missed Wall Street’s revenue and profit expectations, driven by a 12.6% year-over-year decline in sales and weaker performance in private equity realizations. Management attributed the underperformance primarily to a quieter quarter for private equity exits and volatile public markets, while highlighting ongoing strength in credit and secondary solutions. CEO Harvey Schwartz acknowledged, “It’s just part of the private equity business. It’s hard to control when deals close, and it is what it is,” emphasizing the multi-quarter nature of deal activity and the focus on long-term trends over short-term results.

Private equity firm Carlyle Group (NASDAQ:CG) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 12.6% year on year to $782.5 million. Its non-GAAP profit of $0.87 per share was 15% below analysts’ consensus estimates.

Financial institutions play a critical role, offering everything from consumer banking to wealth management and specialized financial solutions. Still, investors are uneasy as companies face challenges from an unpredictable interest rate and inflation environment. These doubts have certainly contributed to the indutry's recent underperformance - over the past six months, its 10.9% gain has fallen behind the S&P 500's 21% rise.

Shares of private equity firm Carlyle Group (NASDAQ:CG) fell 5.7% in the afternoon session after the company reported third-quarter financial results where revenue fell significantly short of analysts' expectations, alongside a slight miss on fee-related earnings. The global investment firm generated revenue of $782.5 million, a 12.6% decline from the previous year and a 20.7% miss against Wall Street's forecast of $987.3 million. Additionally, fee-related earnings, a key measure of recurring profitability for asset managers, came in at $311.9 million, narrowly missing estimates. The results were not all negative, as the firm's Assets Under Management (AUM) grew 5.9% year-over-year to $474 billion, beating expectations by 6%. However, investors appeared to focus on the significant revenue shortfall, which drove the negative sentiment around the stock.